Top Markets
Coin of the day
LAVA Therapeutics N.V. LAVA Therapeutics N.V.

LAVA Therapeutics N.V.

LVTX
Xếp hạng trong cổ phiếu #25847
LAVA Therapeutics N.V. is an immuno-oncology firm, currently in the clinical... LAVA Therapeutics N.V. is an immuno-oncology firm, currently in the clinical development phase, dedicated to pioneering novel therapies for cancer. Utilizing its proprietary Gammabody platform, the company engineers innovative bispecific antibodies. These antibodies are specifically designed to engage and harness the potent and precise capabilities of gamma delta T cells, aiming to stimulate a robust anti-tumor immune response and ultimately enhance outcomes for individuals battling cancer. Key compounds in its clinical pipeline include LAVA-051, currently undergoing Phase 1/2a trials for various hematologic malignancies such as chronic lymphocytic leukemia, multiple myeloma, and acute myeloid leukemia. Another front-runner, LAVA-1207, is also in Phase 1/2a clinical studies, targeting metastatic castration-resistant prostate cancer. Furthermore, LAVA Therapeutics is advancing additional Gammabody candidates: LAVA-1223, an investigational treatment for specific solid tumors that targets the epidermal growth factor receptor (EGFR), and preclinical assets LAVA-1266 and LAVA-1278, intended for a range of blood cancers. The company has also forged a research collaboration and licensing partnership with Janssen Biotech, Inc. This alliance focuses on the potential discovery and development of multi-specific antibody therapies aimed at a particular target across diverse therapeutic applications. Established in 2016, LAVA Therapeutics N.V. operates from its headquarters in Utrecht, the Netherlands.
Giá cổ phiếu
$1.74
Đồng bộ lần cuối: 2025-11-28
Vốn hóa thị trường
$45.77M
Thay đổi (1 ngày)
0.00%
Thay đổi (1 năm)
12.26%
Quốc gia
NL
Giao dịch LAVA Therapeutics N.V. (LVTX)

Danh mục

Lịch sử giá cổ phiếu của LAVA Therapeutics N.V. (LVTX)
Giá đóng cửa cao nhất: $1.68 vào 2025-11-01

Giá đóng cửa thấp nhất: $13.74 vào 2021-03-01
Lịch sử giá cổ phiếu của LAVA Therapeutics N.V. từ 2021 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) -5.21%
2025 33.22%
2024 -17.20%
2023 -67.44%
2022 -17.89%
2021 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
$539.14 35.65%
US
$1.04K 56.21%
NL
$119.69 -17.56%
AU
$761.87 8.65%
CH
$130.43 397.46%
US